Cargando…
Multiple sclerosis: Possible immunological mechanisms()
Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic,...
Autores principales: | McFarland, Henry F., Dhib-Jalbut, Suhayl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133204/ https://www.ncbi.nlm.nih.gov/pubmed/2521315 http://dx.doi.org/10.1016/0090-1229(89)90116-5 |
Ejemplares similares
-
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives
por: Bhise, Vikram, et al.
Publicado: (2021) -
Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
por: Yadav, Sudhir Kumar, et al.
Publicado: (2023) -
Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells
por: Dhib-Jalbut, Suhayl, et al.
Publicado: (1990) -
Mechanism of measles virus failure to activate NF-κB in neuronal cells
por: Fang, Yu -Yan, et al.
Publicado: (2001) -
Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis
por: Ito, Kouichi, et al.
Publicado: (2021)